Centrally administered Ac-YVAD-cmk inhibits neuronal damage and apoptosis in rats

被引：0
|
作者：
Hadingham, SJ [1 ]
Mackay, KB [1 ]
King, PD [1 ]
Roberts, JC [1 ]
Stretton, JL [1 ]
Charles, KJ [1 ]
Patel, S [1 ]
James, MF [1 ]
Campbell, CA [1 ]
Hamilton, TC [1 ]
机构：
[1] SmithKline Beecham Pharmaceut, Neurosci Res, Harlow CM19 5AW, Essex, England
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 1997年 / 122卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
428P
引用
收藏
页码：U136 / U136
页数：1
相关论文
共 50 条
  • [1] AC-YVAD-CMK Inhibits Pyroptosis and Improves Functional Outcome after Intracerebral Hemorrhage
    Lin, Xiao
    Ye, Haotuo
    Siaw-Debrah, Felix
    Pan, Sishi
    He, Zibin
    Ni, Haoqi
    Xu, Zhu
    Jin, Kunlin
    Zhuge, Qichuan
    Huang, Lijie
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [2] Caspase-1-Inhibitor AC-YVAD-CMK Inhibits Pyroptosis and Ameliorates Acute Kidney Injury in a Model of Sepsis
    Yang, Mei
    Fang, Jin-tao
    Zhang, Ni-shang
    Qin, Long-jiang
    Zhuang, Yang-yang
    Wang, Wei-wei
    Zhu, Hai-ping
    Zhang, Yan-jie
    Xia, Peng
    Zhang, Yan
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [3] Ac-YVAD-cmk ameliorated sevoflurane-induced cognitive dysfunction and revised mitophagy impairment
    Zheng, Du
    Wang, Hongwei
    Zhou, Youfa
    Chen, Yeru
    Chen, Gang
    PLOS ONE, 2023, 18 (01):
  • [4] Inhibition of Langerhans cell migration by caspase-1 inhibitor, Ac-YVAD-cmk, in mice
    Antonopoulos, C
    Cumberbatch, M
    Dearman, RJ
    Kimber, I
    Groves, RW
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (03) : 535 - 535
  • [5] Ac-YVAD-cmk improves neurological function by inhibiting caspase-1-mediated inflammatory response in the intracerebral hemorrhage of rats
    Liang, Hongsheng
    Sun, Yong
    Gao, Aili
    Zhang, Nannan
    Jia, Ying
    Yang, Shanshan
    Na, Meng
    Liu, Huailei
    Cheng, Xingbo
    Fang, Xiaofeng
    Ma, Wei
    Zhang, Xiangtong
    Wang, Fan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 75
  • [6] Hope for vascular cognitive impairment: Ac-YVAD-cmk as a novel treatment against white matter rarefaction
    Lim, Yun-An
    Tan, Li Si
    Lee, Wei Thye
    Sim, Wei Liang
    Lv, Yang
    Takakuni, Maki
    Saito, Satoshi
    Ihara, Masafumi
    Arumugam, Thiruma Valavan
    Chen, Christopher
    Wong, Fred Wai-Shiu
    Dawe, Gavin Stewart
    PLOS ONE, 2024, 19 (04):
  • [7] Caspase-1-inhibitor ac-YVAD-cmk reduces LPS-lethality in rats without affecting haematology or cytokine responses
    Mathiak, G
    Grass, G
    Herzmann, T
    Luebke, T
    Zetina, CC
    Boehm, SA
    Bohlen, H
    Neville, LF
    Hoelscher, AH
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 (03) : 383 - 386
  • [8] AC-YVAD-CMK prevents NLRP3 inflammasome activation and pyroptosis in animal model of depression.
    Trojan, E.
    Kurek, A.
    Chamera, K.
    Bryniarska, N.
    Szuster, M.
    Strzelec, M.
    Basta-Kaim, A.
    GLIA, 2019, 67 : E573 - E574
  • [9] Ac-YVAD-cmk improves neurological function by inhibiting caspase-1-mediated inflammatory response in the intracerebral hemorrhage of rats (vol 75, 105771, 2019)
    Liang, Hongsheng
    Sun, Yong
    Gao, Aili
    Zhang, Nannan
    Jia, Ying
    Yang, Shanshan
    Na, Meng
    Liu, Huailei
    Cheng, Xingbo
    Fang, Xiaofeng
    Ma, Wei
    Zhang, Xiangtong
    Wang, Fan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 119
  • [10] Neuroprotective effects of Ac.YVAD.cmk on experimental spinal cord injury in rats
    Karaoglan, Alper
    Kaya, Ekrem
    Akdemir, Osman
    Sagmanligil, Ayhan
    Bilguvar, Kaya
    Cirakoglu, Beyazit
    Sahan, Elife
    Erdogan, Nusret
    Barut, Seref
    Colak, Ahmet
    SURGICAL NEUROLOGY, 2008, 69 (06): : 561 - 567
12345